These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7037955)

  • 1. Elevated direct and IgM enhanced ADCC activity in multiple sclerosis patients.
    Merrill JE; Wåhlin B; Sidén A; Perlmann P
    J Immunol; 1982 Apr; 128(4):1728-35. PubMed ID: 7037955
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effect of interferon expression of IgG- and IgM-Fc receptors on human lymphocytes.
    Itoh K; Inoue M; Kataoka S; Kumagai K
    J Immunol; 1980 Jun; 124(6):2589-95. PubMed ID: 6154733
    [No Abstract]   [Full Text] [Related]  

  • 3. A T lymphocyte subpopulation in multiple sclerosis patients bearing Fc receptors for both IgG and IgM1.
    Merrill JE; Biberfeld G; Kolmodin G; Landin S; Norrby E
    J Immunol; 1980 Jun; 124(6):2758-64. PubMed ID: 6966297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An HLA-D-linked low response to polyclonal B-cell activation in multiple sclerosis.
    Paty DW; Cousin HK; Stiller CR; Dossetor JB
    Transplant Proc; 1978 Dec; 10(4):973-5. PubMed ID: 366836
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density.
    Niwa R; Sakurada M; Kobayashi Y; Uehara A; Matsushima K; Ueda R; Nakamura K; Shitara K
    Clin Cancer Res; 2005 Mar; 11(6):2327-36. PubMed ID: 15788684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD16+ gammadelta T cells mediate antibody dependent cellular cytotoxicity: potential mechanism in the pathogenesis of multiple sclerosis.
    Chen Z; Freedman MS
    Clin Immunol; 2008 Aug; 128(2):219-27. PubMed ID: 18501678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of homology between human and chicken K cells.
    Nowak J
    Arch Immunol Ther Exp (Warsz); 1981; 29(3):407-11. PubMed ID: 7294975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of IgG-IgM interplay by antibody specificity in human K-cell-mediated cytotoxicity.
    Ohlander C; Perlmann H; Perlmann P
    Scand J Immunol; 1982 Apr; 15(4):409-17. PubMed ID: 7100819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer activity of human lymphocytes against colon cancer cells.
    Helms RA; Bull DM
    Gastroenterology; 1980 Apr; 78(4):738-44. PubMed ID: 7353760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cells--immunologist's fancy?
    Gupta S
    Gastroenterology; 1980 Apr; 78(4):865-7. PubMed ID: 6965484
    [No Abstract]   [Full Text] [Related]  

  • 11. Natural killer cell activity in multiple sclerosis.
    Hauser SL; Ault KA; Levin MJ; Garovoy MR; Weiner HL
    J Immunol; 1981 Sep; 127(3):1114-7. PubMed ID: 6167616
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of IgG antibody-dependent cellular cytotoxicity in vitro by IgM antibodies.
    Perlmann H; Perlmann P; Moretta L; Rönnholm M
    Scand J Immunol; 1981 Jul; 14(1):47-60. PubMed ID: 7313557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identity of effector cells participating in the reverse antibody-dependent cell-mediated cytotoxicity.
    Saxena RK; Saxena QB; Adler WH
    Immunology; 1982 Jun; 46(2):459-64. PubMed ID: 7084998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
    Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
    Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The lymphocyte abnormality in CNS disease].
    Matsubara H; Igata A
    No To Shinkei; 1983 May; 35(5):423-31. PubMed ID: 6354216
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of gamma-interferon and phorbol myristate acetate on the Fc gamma-receptor ligand-binding capacity and on the target-conjugating and antibody-dependent cytotoxic activity of blood lymphocytes].
    Miliukiene VV; Dediniene JL
    Tsitologiia; 1997; 39(8):681-7. PubMed ID: 9490506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the cytologic characteristics of antibody-dependent cellular cytotoxicity of normal and leukemic bovine blood lymphocytes.
    Adomaitiene D; Dediniene J
    Anal Quant Cytol; 1981 Jun; 3(2):143-8. PubMed ID: 7258857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective mononuclear cell antibody-dependent cellular cytotoxicity (ADCC) in patients with leukocyte adhesion deficiency emphasizing on different CD11/CD18 requirement of Fc gamma RI versus Fc gamma RII in ADCC.
    Majima T; Ohashi Y; Nagatomi R; Iizuka A; Konno T
    Cell Immunol; 1993 May; 148(2):385-96. PubMed ID: 8098672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between antibody-dependent cell-mediated cytotoxicity due to anti-HTLV-1 and negative signal of major histocompatibility complex class I antigens on adult T-cell leukemia cell lines.
    Komatsu F; Tamiya H
    Oncol Res; 1998; 10(2):59-67. PubMed ID: 9666513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells.
    Ault KA; Springer TA
    J Immunol; 1981 Jan; 126(1):359-64. PubMed ID: 7451976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.